Key result
Mutations at position 63 of the VP3 capsid protein (aromatic substitutions and N63D) significantly reduced the release of membrane-associated viral particles and increased viral spread in cell culture.
Why the study?
Enteroviruses can be released non-lytically in extracellular vesicles, but the molecular mechanisms governing CVB3 egress and the role of VP3 capsid protein position 63 remain to be defined.
p-value: p=<0.05
Mutations at position 63 of the CVB3 VP3 capsid protein alter viral release mechanisms, reducing membrane-associated egress while increasing viral spread in cell culture.
VP3-63 mutations modulate CVB3 fitness and EV release; leaves open relevance to non-lytic spread in myocarditis.
Coxsackievirus B3 (CVB3), a member of the Enterovirus genus within the Picornaviridae family, has emerged as a key model for studying viral evolution and pathogenesis. Although traditionally considered obligate lytic viruses, recent research reveals that enteroviruses can also be released non-lytically within extracellular vesicles (EVs). This study explores the impact of mutations at position 63 of the VP3 capsid protein on CVB3 fitness and release mechanisms by substituting asparagine at this position with aromatic, charged, and aliphatic amino acids. We show that mutations at position 63 significantly affect viral release mechanisms and viral spread in cell culture. Specifically, aromatic mutations (N63H, N63Y, N63F, N63W) and the N63D mutation reduce the release of membrane-associated viral particles, while aromatic residues increase viral spread in cell culture and plaque size under specific conditions. These findings suggest that N63 mutations alter protomer interactions, influencing viral release, spread, and plaque formation, providing insights into the molecular mechanisms of CVB3 egress.
No takes yet. Share an insight, caveat, or question.
Arce et al. (2025) studied Coxsackievirus B3 infection (in vitro). VP3 capsid protein mutations at position 63 (N63H, N63Y, N63F, N63W, N63D) vs. Wild-type (WT) CVB3 was evaluated on Percentage of viral progeny released as membrane-associated complexes (p=<0.05). Mutations at position 63 of the VP3 capsid protein (aromatic substitutions and N63D) significantly reduced the release of membrane-associated viral particles and increased viral spread in cell culture.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: